Cytogenetics Dir- San Juan Capistrano, California
Director, Cytogenetics - San Juan Capistrano, CA
Recognized by FORTUNE magazine as one of the "World's Most Admired Companies," Quest Diagnostics is the world's leading provider of diagnostic testing, information and services that doctors and patients need to make better healthcare decisions. They are pioneers in developing innovative diagnostic tests and advanced healthcare information technology solutions that help improve patient care.
With corporate headquarters in Secaucus, NJ, Quest Diagnostics is a Fortune 500 company traded on the New York Stock Exchange (NYSE: DGX) and included in the Dow Jones Sustainability World Index. With 2020 revenues of $9.44 Billion and approximately 50,000 employees and 6,600 patient locations across the US, Quest Diagnostics serves half of the physicians and hospitals in the US with their large variety of products and services.
The company offers the broadest access to diagnostic testing services through its network of laboratories and patient service centers and provides interpretive consultation through its extensive medical and scientific staff. Quest Diagnostics also provides services to employers, life insurance companies, other commercial labs, clinics, health plans, government agencies, and organizations involved in clinical trials research.
Approximately 150 million times each year, patients and their physicians rely upon Quest Diagnostics results to make important healthcare decisions and approximately one third of U.S. physicians - and many of the country's leading hospitals and health systems - relies on Quest Diagnostics healthcare information solutions to foster better patient care and outcomes.
* FORTUNE magazine's "World's Most Admired Companies" list for 7 consecutive years; one of only five companies to attain Most Admired statusin the "Health Care, Pharmacy and Other Services" industry category.
* Fortune magazine's Fortune 500 list
* Forbes Global 2000
* Forbes' America's Best Employers List for third consecutive year
* Forbes 2020 America's Best Employers for Women for second consecutive year
* S&P 500
* Barron's 500
* Member of the Dow Jones Sustainability World Index
* Included in the FTSE4Good, Calvert, and Ocean Tomo sustainability indices
* Listed in the most recent Newsweek Green Rankings
* Consistently named one of the best places to work in U.S. business journal rankings
* Named a DiversityInc Noteworthy Company for third consecutive year
* Listed on the Disability Equality Index (DEI), a joint initiative of the American Association of People with Disabilities (AAPD) and the US Business Leadership Network (USBLN), recognizing companies for prioritizing the inclusion of people with disabilities
* Named Top 23 'Best Places to Work for LGBTQ Equality' in New Jersey
* Named a Best Place to Work for LGBTQ Equality by scoring a perfect 100 on the Human Rights Campaign Foundation's 2021 Corporate Equality Index (CEI) for the fifth consecutive year.
* Achieved Cancer Gold Standard accreditation from the CEO Roundtable on Cancer, recognizing our actions to reduce the cancer risk of employees and their families
* Received C. Everett Koop National Health Award for Efforts to Promote Employee Health in 2020
Diagnostic Testing Services
Quest Diagnostics is the world's leading provider of diagnostic testing, information and services that patients and doctors need to make better healthcare decisions. Their services range from routine blood tests - such as total cholesterol, Pap testing and white blood cell count - to complex, gene-based and molecular testing. They perform medical tests that aid in the diagnosis or detection of diseases, measure the progress or recovery from a disease or confirm that an individual is free from disease. In addition, they have specialized expertise in cancer, cardiovascular diseases, infectious diseases, and neurology.
In the $60 Billion and growing US Diagnostic Testing Market, Quest Diagnostics is the leader. Quest Diagnostics' reputation as a leading innovator, provider of high value, low cost solutions and its financial strength and flexibility make it well positioned to capitalize on the evolving healthcare landscape.
Quest Diagnostics' long-term strategy is to become the undisputed world leader in diagnostic testing, information and services. To drive this profitable growth, Quest Diagnostics plans to leverage capabilities to create differentiation:
* Deliver Innovative Solutions
* Leverage their Unparalleled Access and Distribution Network
* Expand their relationships with large payors and health systems
* Deliver Superior Patient Experiences
The Director, Cytogenetics is responsible for providing interpretation of cytogenetics/FISH results and providing consultation to the clinical laboratory within her/his area(s) of expertise which will maximize quality patient care and ensure continuous business growth throughout the Quest Diagnostics Nichols Institute family of laboratories.
* Scientific: significant collaboration with internal teams as it relates to testing menu, test selection and validation.
* Reviews, interprets, and documents clinical test results within established turnaround times.
* Due to the importance of quality patient care, servicing consultation requests of all types is considered imperative (assists treating physician).
* Collaborates professionally with Laboratory manager, supervisors, technologists and other laboratory operations staff.
* Participates in educational programs of the Company.
* Attendance at National meetings in areas of assigned expertise to maintain/build knowledge and to provide representation for Quest Diagnostics, Nichols Institute. Assists the delegate Clinical Consultant or Technical Supervisor in the responsibilities in Cytogenetics Specialty as delegated by the Laboratory Director Responsibilities.
* Collaborates in reviewing test method selection and validation.
* Collaborates in ensuring that the proficiency testing program is conducted in a timely manner, reviewed by appropriate staff, and approve of corrective action when a proficiency testing result is found to be unsatisfactory.
* Collaborates in monitoring quality control to ensure that acceptable levels of analytical performance are maintained for each test system. Ensure that patient test results are reported only when the system is functioning properly.
* Collaborates in corrective action and preventative action plans and procedures.
* Collaborates in the annual review of Standard Operating Procedures for test systems.
* Collaborates in reviews of report format for appropriateness of clinical information communicated in areas of assigned expertise. Collaborates in review of interpretative reporting comments as needed.
* MD, PhD Degree or equivalent.
* Board Certified in Clinical Cytogenetics and Molecular Genetics by ABMGG and California, and New York Licensed/eligible.
* A minimum of 1-2 years of practical experience in a clinical cytogenetics laboratory.
* Skills/experience in medical publications is desired.
* Chromosomal microarray reporting experience is a must.
* All Cytogenetics Directors should be prepared to demonstrate competence in their fields of practice. Cytogenetics Directors should exemplify professionalism consistent with Quest Diagnostics Nichols Institute's values, vision, mission and fundamental objectives.
Please Log In or Register to Upload a Resume and complete the online Application by visiting , clicking "Job Search" and following the prompts. Because of the large number of applicants to job openings, Quest Diagnostics will only contact qualified candidates for interviews.
Quest Diagnostics is an equal opportunity employer. All applicants will be considered for employment without attention to race, color, religion, sex, sexual orientation, gender identity, national origin, veteran or disability status.
All requirements are subject to possible modifications to reasonably accommodate individuals with disabilities. Quest Diagnostics is an Equal Opportunity Employer: Women / Minorities / Veterans / Disabled / Sexual Orientation / Gender Identity / Citizenship.